Exhibit 99.1

For more information contact:

Alex Edwards
813-264-2241



FOR IMMEDIATE RELEASE


        Nanobac, Inc. Announces the Sale of its Healthcentrics Subsidiary

     TAMPA, Fla. (March 31, 2004) -- Nanobac, Inc. (OTC:NNBP) ("Nanobac" or "The
Company") announces the sale of its medical practice management software
subsidiary, Healthcentrics, to Escape Velocity of Tampa Bay ("Escape"). Escape,
a related party and significant shareholder of the Company, is controlled by
John Stanton, Nanobac's Chairman of the Board. Escape is acquiring
Healthcentrics by assuming all liabilities of Healthcentrics and reducing its
debt position in Nanobac by $250,000.

     "Nanobac is focused on the development of its multi-layer Intellectual
Property associated with Nanobacteria infection and infestation," said Alex
Edwards, Nanobac's CEO and President. "By selling Healthcentrics, the Company
will be reducing its debt, as well as eliminating all non-Nanobacteria related
initiatives and expenditures." The transaction is described in detail in the
Company's Form 10KSB filed March 30, 2004.

     Nanobac, Inc. is headquartered in Tampa, Florida, U.S.A. For more
information, please visit our website at www.nanobaclabs.com or contact us at
                                         -------------------
info@nanobaclabs.com.
- ---------------------

     Investors are cautioned that certain statements contained in this document
as well as some statements in periodic press releases and some oral statements
of Nanobac, Inc. officials are "Forward-Looking Statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act").




Forward-Looking statements include statements which are predictive in nature,
which depend upon or refer to future events or conditions, which include words
such as "believes," "anticipates," "intends," "plans," "expects," and similar
expressions. In addition, any statements concerning future financial performance
(including future revenues, earnings or growth rates), ongoing business
strategies or prospects, and possible future Nanobac, Inc. actions, which may be
provided by management, are also forward-looking statements as defined by the
Act. Forward-Looking statements involve known and unknown risks, uncertainties,
and other factors which might cause the actual results, performance or
achievements of the Company to materially differ from any future results,
performance or achievements expressed or implied by such forward-looking
statements and to vary significantly from reporting period to reporting period.
Although management believes that the assumptions will, in fact, prove to be
correct or that actual future results will not be different from the
expectations expressed in this report, these statements are not guarantees of
future performance and Nanobac, Inc. has no specific intention to update these
statements.